The Cooper Companies, Inc. (NASDAQ:COO) Stake Lessened by Commerce Bank

Commerce Bank lowered its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 2.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 159,902 shares of the medical device company's stock after selling 3,916 shares during the quarter. Commerce Bank owned approximately 0.08% of Cooper Companies worth $14,700,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of COO. Byrne Asset Management LLC purchased a new stake in shares of Cooper Companies in the fourth quarter valued at $33,000. OFI Invest Asset Management purchased a new stake in Cooper Companies in the fourth quarter valued at approximately $34,000. New Age Alpha Advisors LLC purchased a new stake in shares of Cooper Companies during the 4th quarter valued at $38,000. Covestor Ltd grew its position in Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after acquiring an additional 120 shares during the period. Finally, West Financial Advisors LLC purchased a new position in shares of Cooper Companies in the 4th quarter worth about $49,000. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Stock Performance

Shares of Cooper Companies stock traded up $1.20 on Thursday, reaching $82.04. 236,687 shares of the company were exchanged, compared to its average volume of 1,417,211. The Cooper Companies, Inc. has a 1-year low of $69.81 and a 1-year high of $112.38. The firm has a market cap of $16.41 billion, a price-to-earnings ratio of 42.02, a P/E/G ratio of 2.25 and a beta of 1.01. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The company's 50-day moving average is $82.37 and its two-hundred day moving average is $93.11.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. The firm had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on COO shares. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Stifel Nicolaus cut their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Citigroup lowered their target price on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research note on Friday, March 7th. Finally, Piper Sandler restated an "overweight" rating and set a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.